AdvisorShares Psychedelics ETF (PSIL)
NYSEARCA: PSIL · Real-Time Price · USD
19.50
-0.13 (-0.66%)
Apr 28, 2026, 11:31 AM EDT - Market open
PSIL Holdings Information
PSIL is an equity ETF with a total of 32 individual holdings. The top holdings are AtaiBeckley stock at 11.08%, COMPASS Pathways at 9.97%, Relmada Therapeutics at 8.68%, Definium Therapeutics at 8.66%, and GH Research at 5.58%.
Total Holdings
32
Top 10 Percentage
68.26%
Asset Class
Equity
ETF Category
Miscellaneous Sector
Assets
31.47M
PE Ratio
n/a
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | ATAI | AtaiBeckley Inc. | 11.08% |
| 2 | CMPS | COMPASS Pathways plc | 9.97% |
| 3 | RLMD | Relmada Therapeutics, Inc. | 8.68% |
| 4 | DFTX | Definium Therapeutics, Inc. | 8.66% |
| 5 | GHRS | GH Research PLC | 5.58% |
| 6 | NRXP | NRx Pharmaceuticals, Inc. | 5.46% |
| 7 | CSE: DRUG | Bright Minds Biosciences Inc. | 5.08% |
| 8 | NEO: HELP | Cybin Inc. | 4.63% |
| 9 | STIM | Neuronetics, Inc. | 4.56% |
| 10 | ANRO | Alto Neuroscience, Inc. | 4.56% |
| 11 | NBIX | Neurocrine Biosciences, Inc. | 4.14% |
| 12 | ALKS | Alkermes plc | 3.88% |
| 13 | SUPN | Supernus Pharmaceuticals, Inc. | 3.67% |
| 14 | ABBV | AbbVie Inc. | 3.66% |
| 15 | JNJ | Johnson & Johnson | 3.58% |
| 16 | NEUP | Neuphoria Therapeutics Inc. | 3.40% |
| 17 | CSE: QNTM | Quantum BioPharma Ltd. | 1.96% |
| 18 | KTTA | Pasithea Therapeutics Corp. | 1.62% |
| 19 | SILO | Silo Pharma, Inc. | 1.51% |
| 20 | PBM | Psyence Biomedical Ltd. | 1.15% |
| 21 | TSX: NUMI | Numinus Wellness Inc. | 1.02% |
| 22 | VTGN | Vistagen Therapeutics, Inc. | 0.69% |
| 23 | IGC | IGC Pharma, Inc. | 0.51% |
| 24 | IXHL | Incannex Healthcare Inc. | 0.42% |
| 25 | ENVB | Enveric Biosciences, Inc. | 0.32% |
As of Apr 24, 2026